Marked Choroidal Thinning Observed after Intravitreal Brolucizumab Injection

INTRODUCTION: Here, we report a case of severe intraocular inflammation (IOI) and prominent choroidal thinning following the initial intravitreal brolucizumab injection (IVBr). CASE PRESENTATION: The patient was a 75-year-old Japanese man with type 2 age-related macular degeneration of both eyes. Un...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueta, Yoshiki, Kamada, Ryoma, Watanabe, Yuji, Tanaka, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645462/
https://www.ncbi.nlm.nih.gov/pubmed/38023610
http://dx.doi.org/10.1159/000534817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645462/
https://www.ncbi.nlm.nih.gov/pubmed/38023610
http://dx.doi.org/10.1159/000534817

Ejemplares similares